MLS® in post-oncology treatment: an interview with specialist Kate Perkins

Kate Perkins, owner of “Cancer Rehabilitation and Lymphatic Solutions” and a long-time user of the M6 and M8 device, has no doubts: MLS® Laser Therapy has proven effective in reducing symptoms related to the effects of anti-tumour therapies and lymphedema in patients.

How and why did you decide to incorporate laser therapy into your practice?
I'm cancer rehabilitation and lymphatic specialist, occupational therapist, and laser has been in my clinic since 2017 to treat the side effects of cancer treatment and lymphedema symptoms. I introduced MLS into my practice in 2021.  

Please accept statistics cookies to watch this video.

How did you learn about MLS® Laser Therapy?
So at one of our trade shows, lymphology trade shows back in 2021, I met Doctor Catherine Norton, who had a stand with an MLS laser. And as soon as I knew the benefits of the MLS® laser I was keen to get one into my practice.

What led you to try laser therapy for such a "delicate" application?
The side effects of cancer treatments and lymphedema can be quite painful, so delivering a treatment that is not invasive is crucial to my practice.

What benefits have you seen in your patients after laser treatments?
Some of the side effects of cancer treatment can include post operative healing, radiation fibrosis, the development of lymphedema symptoms and chemo induced peripheral neuropathy. So I have observed and my patients have experienced some incredible outcomes in reduction in symptoms and their recovery from treatment is so fast and discharge of care is fast, so they are happy to get back to doing their normal day-to-day activities faster. It is quite incredible. 

And what is their feedback?
Their feedback is wow, this is amazing, and they feel so much better. And that is common. I get to see that every day and having that reaction every day makes my job satisfaction, so much nicer every day. 

Please describe ASAlaser with 3 adjectives.
Powerful, sleek and revolutionary.

You might also be interested in ...

See all articles

blog - 11/09/2024
This research, conducted using the M6 robotic device, is the first of its kind to explore this application, offering new hope to patients suffering from this debilitating side effect of radiotherapy.
2023 MASCC Clinical Guidelines
blog - 28/06/2023
The authors found that PBMT was more efficient in the prevention of ARD compared to standard care and/or placebo, particularly in patients with breast cancer.
MLS nella prevenzione della radiodermite acuta - Limburg Oncologic Laser Institute
blog - 16/02/2023
Two recently published studies have investigated the efficacy of MLS® Laser Therapy in the prevention of acute radiodermatitis in patients with breast cancer.
2024 ASAlaser activities
News - 11/12/2024
Whether it’s by taking part in Congresses and Fairs or organising on-site courses or webinars, once again in 2024 ASA has proved to be highly proactive in both the human and veterinary fields.
El.En. e ASA unite nello sviluppo tecnologico
News - 09/12/2024
Research and Development are the pillars on which all the companies of the El.En. Group base their growth: technological innovation, continuous training and know-how sharing are the key words that...
MLS Laser Therapy Workshop @ Melbourne
News - 28/11/2024
Two days of analysis and seminars focused on MLS® Laser Therapy with the support of laser therapy authorities.